SWHR is deeply concerned and discouraged to see that the Administration has deprioritized research and development in the 2018 budget through substantial decreases for critical federal agencies, expressed Dr. Amy M. Miller, SWHR president and CEO.
This guest blog by Judette Louis MD, MPH from University of South Florida and SWHR Interdisciplinary Network on Sleep Member and Mary Ashley Cain MD from University of South Florida explores the overlaps of sleep and pregnancy.
Distinguished physician and health policy expert, Dr. Scott Gottlieb, has been confirmed by the Senate as the next Food and Drug Administration (FDA) Commissioner. President Donald Trump nominated him in March 2017.
The Senate Committee on Health, Education, Labor, and Pensions (HELP Committee) recently voted in favor of Dr. Scott Gottlieb to be the next commissioner of the FDA.
This guest blog by Amita Sehgal, PhD from University of Pennsylvania and SWHR Interdisciplinary Network on Sleep Member and Paula Haynes, PhD from University of Pennsylvania explores circadian disorders.
The scientific community will gather this Earth Day, April 22, to take a public stand “to defend the vital role science plays in health, safety, economies, and governments,” at a March for Science event taking place in more than 500 cities across the world.
SWHR hired Sarah Wells Kocsis, MBA, as its new Vice President of Public Policy.
SWHR appointed Anne B. Cropp, PharmD, Founder and Chief Scientific Officer for Early Access Care, LLC as a new member to its Board of Directors.
SWHR held its Second Annual Awards Dinner Symposium: The State of Women’s Health in Washington, DC, on March 22, 2017, gathering some of the best minds in health policy to discuss advancements in women's health, and to explore existing policy challenges in understanding gender and ethnic disparities in health.